Table 4. Inhibitor Eradication Trial:... | American Society of Hematology

Table 4.

Inhibitor Eradication Trial: power simulations (n = 90)

Eradication rate in the emicizumab arm, %	Power, %*
96.0	74
96.3	79
96.6	81
96.9	82

There is 81% power to detect a difference of 96.6% between trial arms, with 90 subjects and α = 0.05.

This assumes the eradication rate in the ELOCTATE ITI arm is 80%.